[Progress in Research and Application of Drug-Device Combination Product].

Autor: Tang K; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#., Zhou J; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#., Li Y; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#., Qu M; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#., Wang Y; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#., Luo J; Shanghai MicroPort Medical(Group) Co., Ltd., Shanghai, 201203. ##Email#.
Jazyk: čínština
Zdroj: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2020 Jan 08; Vol. 44 (1), pp. 51-55.
DOI: 10.3969/j.issn.1671-7104.2020.01.011
Abstrakt: Drug-device combination product, which comprises at least a drug and a medical device, has been proved to effectively reduce the risk of complications accompanied with conventional medical devices implantation, and has a great clinical success especially in implantable therapeutics. Herein, we firstly elaborated the definitions and requirements of drug-device combination product in different countries, then summarized the market application and research development of typical drug-device combination products. Technical problems and the trend of future development had also been analyzed.
Databáze: MEDLINE